Document Type : Original Article
Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University,Lahijan,Iran
Objective: Rubella is a viral disease with minor morbidity, unless it is contracted by a pregnant woman in early pregnancy that leads to congenitalRubella syndromes. Rubella occurrence during the first trimester leads to fetal death or severe congenital defects.Present study was conducted to survey the protection level against Rubella in the pregnant women of Gilan in IRAN,to be used for the vaccination and prevention programs.Methods: This investigation was carried out in six cities of the province,97 pregnant women aged between 17-38 years old serum samples were taken, Serum IgG and IgM levels were measured by inhibitory competitive ELISA.All cases had a protective level of anti-rubella IgG due to 10(positive) determination,Whereas two women had an equivocal level of IgM referred to 1.1(positive) calculations. Results: According to the obtained results 2.06% of women were suspected to active Rubella infection. Significant correlations were found between seroprevalence of rubella IgG and geographical residency and seasonal fluctuations. Discussion: Our findings indicated that population general immunity exists nowadays,but this immunity level might not only be a result of vaccination,we strongly recommend routine antirubella IgG screening for women at the age of childbearing before marriage or conception as well as vaccinating non immune women.
Adam O, Makkawi T, Kannan A. Seroprevalence of rubella among pregnant women in Khartoum state , Sudan. East Medit Heal J , 19 :812-15.
Chiang Lin C, Yuh Yang C and Tang Shih C ,2010 . Rubella Seroepidemiology and Catch-up Immunization among Pregnant Women in Taiwan: Comparison between Women Born in Taiwan and Immigrants from Six Countries in Asia. Am J Trop Med Hyg. 82,40-4.
Chantler S, Evans CJ and Mortimer PP ,1982. A comparison of antibody capture radio and enzyme immunoassays with immunofluorescence for detecting IgM antibody in infants with congenital rubella. J Viro Meth . 4,305-13.
Centers for Disease Control .Control and prevention of rubella, 2001 . evaluation and management of suspected outbreaks. rubella in pregnant women , and surveillance for congenital rubella syndrome. MMWR Recomm Rep. 50, 1–23.
Esteghamati A , Gouya MM and Zahraei SM, 2007. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J . 26, 1137–41.
El Sayed N , Kandeel N and Barakat I, 2011. Progress Toward Measles and Rubella Elimination in Egypt. J Inf Dis. 204,318–24.
Hussein N, Jaffery GH and Hasnain SH ,2006. Seroprevalence of Rubella IgG and IgM antibodies in infants suspected of having Rubella infection .
Biomedica . 22 ,25-3.
Honarvar B ,Moghadami M, and Moattari A , 2013. Seroprevalence of Anti-Rubella and Anti-Measles IgG Antibodies in Pregnant Women in Shiraz, Southern Iran: Outcomes of a Nationwide Measles-Rubella Mass Vaccination Campaign. PLOS ONE. 8,1-8.
Hamkar R, Jalilvand S and Mokhtari-Azad T, ,2006. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003 . Am J Infect Control . 34, 588–92.
Halperin SA , Ferrera G and Scheifele D ,2009 . Safety and immunogenicity of a measles-mumps-rubellavaricella vaccine given as a second dose in children
up to six years of age. Vaccine . 27,2701-06.
Mahmoodi M and Vahedi E, 2007. Comparison of rubella immunity of Mashhad’s women before and after Measles–Rubella mass campaigns 2003–2005 .Med J Mash Uni Med Sci . 50,177–86 .
Namaei M, Ziaee M and Naseh N , 2008. Congenital rubella syndrome in infants of women vaccinated during or just before pregnancy with measles-rubella vaccine. Indian J Med Res . 127 ,551-54.
Obijimi TO , Ajetomobi AB and Sule WF,2013. Prevalence of Rubella virus Specific immunoglobulin G and M in pregnant women attending two tertiary hospitals in southwestern NIGERIA . Afr J Clin Exper Mic. 14,134-9.
Ouyahia A, Segueni A and Laouamri S , ,2013.
Seroprevalence of rubella among women of childbearing age in Algeria. Is there a need for a rubella vaccination. Int J Pub Heal Epi . 2,56-9.
Pourabbas B, Ziyaeyan M and Alborzi A ,2008. Efficacy of measles and rubella
vaccination one year after the nationwide campaign in Shiraz, Iran .Int J Infect Dis. 12,43–46.
Raut SK , Kulkarni PS and Phadke MA , 2007. Persistence of Antibodies Induced by Measles-MumpsRubella Vaccine in Children in India. Clin Vac Immunol. 14 ,1370–71.
Shamsizadeh A , Nikfar R and Makvandi M ,2012. Seroprevalence Measles , Mumps and Rubella antibodies in 18 months and 6.5 years old children :
Six monthes after Measles , Mumps and Rubella (MMR) vaccination. Joundishapour microbial. 4, 578-81.
Vauloup-Fellous C, Grangeot-Keros L,2007. Humoral Immune Response after Primary Rubella Virus Infection and after Vaccination. Clin Vac Immunol . 14,
World Health Organization. WHO/IVB Database.2006 and the World Population Prospects : the 2004 Revision.
World Health Organization. WHO Vaccine-Preventable Diseases : Monitoring System 2008 Global Summary.Available at <http://www.who.int/immunization/documents/en/.
World Health Organization ,1991. Rubella and congenital rubella syndrome in